Gene · 8398
Papers2,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring therapeutic potential of mitophagy modulators using Drosophila models of Parkinson's disease. | Front Aging Neurosci | 2022 | 36337696 | PubTator, text mining | PubMed |
| A multicenter study of genetic testing for Parkinson's disease in the clinical setting. | NPJ Parkinsons Dis | 2022 | 36333361 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Membrane Association Allosterically Regulates Phospholipase A2 Enzymes and Their Specificity. | Acc Chem Res | 2022 | 36315840 | PubTator, text mining | PubMed |
| Biological Properties and Clinical Significance of Lipoprotein-Associated Phospholipase A2 in Ischemic Stroke. | Cardiovasc Ther | 2022 | 36313479 | PubTator, text mining | PubMed |
| GPX4-independent ferroptosis-a new strategy in disease's therapy. | Cell Death Discov | 2022 | 36309489 | PubTator, text mining | PubMed |
| Multifunctional role of natural products for the treatment of Parkinson's disease: At a glance. | Front Pharmacol | 2022 | 36299886 | PubTator, text mining | PubMed |
| Chromogranin A and Its Fragments in the Critically Ill: An Expanding Domain of Interest for Better Care. | Pharmaceutics | 2022 | 36297613 | PubTator, text mining | PubMed |
| Recent Advances in Multifunctional Antimicrobial Peptides as Immunomodulatory and Anticancer Therapy: Chromogranin A-Derived Peptides and Dermaseptins as Endogenous versus Exogenous Actors. | Pharmaceutics | 2022 | 36297449 | PubTator, text mining | PubMed |
| A Review of Herbal Medicine-Based Phytochemical of Garcinia as Molecular Therapy for Breast Cancer. | Drug Des Devel Ther | 2022 | 36248245 | PubTator, text mining | PubMed |
| Clinical and genetic characterization of a Taiwanese cohort with spastic paraparesis combined with cerebellar involvement. | Front Neurol | 2022 | 36247768 | PubTator, text mining | PubMed |
| Comprehensive analysis of immune ferroptosis gene in renal clear cell carcinoma: prognosis and influence of tumor microenvironment. | Am J Transl Res | 2022 | 36247256 | PubTator, text mining | PubMed |
| The prognostic value of arachidonic acid metabolism in breast cancer by integrated bioinformatics. | Lipids Health Dis | 2022 | 36243728 | PubTator, text mining | PubMed |
| Ferroptosis and its emerging role in esophageal cancer. | Front Mol Biosci | 2022 | 36237575 | PubTator, text mining | PubMed |
| Genome Sequencing and Transcriptome Profiling in Twins Discordant for Mayer-Rokitansky-Küster-Hauser Syndrome. | J Clin Med | 2022 | 36233463 | PubTator, text mining | PubMed |
| Mutations, Genes, and Phenotypes Related to Movement Disorders and Ataxias. | Int J Mol Sci | 2022 | 36233161 | PubTator, text mining | PubMed |
| Molecular Characterization and In Silico Analyses of Maurolipin Structure as a Secretory Phospholipase A 2 (sPLA2) from Venom Glands of Iranian Scorpio maurus (Arachnida: Scorpionida). | J Trop Med | 2022 | 36226273 | PubTator, text mining | PubMed |
| Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers. | Neuroimage Clin | 2022 | 36223668 | PubTator, text mining | PubMed |
| Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer's dementia. | Alzheimers Res Ther | 2022 | 36217192 | PubTator, text mining | PubMed |
| Extremely Early-Onset Frontotemporal Dementia: A Case Report and Literature Review. | J Alzheimers Dis | 2022 | 36214000 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8398/papers?page=19